These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4345217)

  • 41. [Hypsarrhythmia after triple vaccination].
    Kringelbach J; Senstius J
    Nord Med; 1966 Dec; 76(49):1433-6. PubMed ID: 4380915
    [No Abstract]   [Full Text] [Related]  

  • 42. Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice.
    Takahashi Y; Hasegawa H; Hara Y; Ato M; Ninomiya A; Takagi H; Odagiri T; Sata T; Tashiro M; Kobayashi K
    J Infect Dis; 2009 Jun; 199(11):1629-37. PubMed ID: 19385735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Need for monitoring vaccinated populations for immunity levels.
    Horstmann DM
    Prog Med Virol; 1973; 16():215-40. PubMed ID: 4585486
    [No Abstract]   [Full Text] [Related]  

  • 44. [Antigen-containing bone marrow cells of mice immunized with a number of antiviral vaccines].
    Nabokova AV; Cherkeziia SE; Mikhaĭlova GR; Gorshunova LP
    Vopr Virusol; 1980; (4):454-7. PubMed ID: 6158797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection.
    Aricò E; Robertson KA; Belardelli F; Ferrantini M; Nash AA
    Vaccine; 2004 Mar; 22(11-12):1433-40. PubMed ID: 15063566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
    McCurdy LH; Larkin BD; Martin JE; Graham BS
    Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.
    Ninomiya A; Imai M; Tashiro M; Odagiri T
    Vaccine; 2007 May; 25(18):3554-60. PubMed ID: 17293015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
    J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunity tests with a Hong Kong strain influenza virus lethal to mice].
    Herzberg K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):298-303. PubMed ID: 5456375
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunization practices and controversies 1981: Part 1-The "big seven" vaccines.
    Backes CR
    J Am Osteopath Assoc; 1981 May; 80(9):595-603. PubMed ID: 7251409
    [No Abstract]   [Full Text] [Related]  

  • 52. [Antiviral therapy of herpetic lesions of the nervous system].
    Akimov GA; Lobzin VS; Mikhaĭlenko AA; Smorodintsev AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):191-6. PubMed ID: 205067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antigenicity of 4 antiviral vaccines].
    Ruiz-Gómez J
    Gac Med Mex; 1973 Jun; 105(6):599-608. PubMed ID: 4731998
    [No Abstract]   [Full Text] [Related]  

  • 54. Advice for travelers.
    Med Lett Drugs Ther; 1999 Apr; 41(1051):39-42. PubMed ID: 10368704
    [No Abstract]   [Full Text] [Related]  

  • 55. Inactivated vaccine for protection against duck virus enteritis.
    Shawky SA; Sandhu TS
    Avian Dis; 1997; 41(2):461-8. PubMed ID: 9201416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ACTION OF ENDOGENOUS INTERFERON AGAINST VACCINIA INFECTION IN CHILDREN.
    PETRALLI JK; MERIGAN TC; WILBUR JR
    Lancet; 1965 Aug; 2(7409):401-5. PubMed ID: 14346758
    [No Abstract]   [Full Text] [Related]  

  • 57. [Report of the results obtained in the treatment of herpes with a new inactivated vaccine].
    Lépine P; De Rudder J
    Sem Ther; 1964 Oct; 40(8):469-74. PubMed ID: 4293021
    [No Abstract]   [Full Text] [Related]  

  • 58. [Interferon production and non-specific protective reactions in the central nervous systems of animals vaccinated with live measles vaccine].
    Gorshunova LP; Bektemirov TA; Koshtoian SE
    Vopr Virusol; 1971; 16(6):735-9. PubMed ID: 5141616
    [No Abstract]   [Full Text] [Related]  

  • 59. The need for a standardised cell substrate for virus vaccine production.
    Perkins FT
    Jpn J Med Sci Biol; 1971 Oct; 24(5):329-35. PubMed ID: 5003824
    [No Abstract]   [Full Text] [Related]  

  • 60. [Several aspects of antiviral immunity].
    Solov'ev VD
    Vestn Akad Med Nauk SSSR; 1979; (1):30-4. PubMed ID: 419861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.